Cytek Biosciences/$CTKB
About Cytek Biosciences
Ticker
Industry
Employees
CTKB Metrics
$935M
-
-$0.08
1.32
-
Price and volume
Market cap
$935M
Beta
1.32
52-week high
$9.33
52-week low
$4.66
Average daily volume
630K
Financial strength
Current ratio
6.214
Quick ratio
5.262
Long term debt to equity
2.333
Total debt to equity
3.766
Interest coverage (TTM)
-20.35%
Management effectiveness
Return on assets (TTM)
-2.74%
Return on equity (TTM)
-2.54%
Valuation
Price to revenue (TTM)
4.753
Price to book
2.44
Price to tangible book (TTM)
2.7
Price to free cash flow (TTM)
33.548
Growth
Revenue change (TTM)
9.88%
Earnings per share change (TTM)
-26.23%
3-year revenue growth (CAGR)
18.91%
3-year earnings per share growth (CAGR)
91.58%
What the Analysts think about CTKB
Analyst Ratings
CTKB Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
CTKB Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
CTKB News
FAQs
What’s the current market cap for Cytek Biosciences stock?
What is the P/E ratio for Cytek Biosciences stock?
Does Cytek Biosciences stock pay dividends?
No, Cytek Biosciences (CTKB) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Cytek Biosciences dividend payment date?
Cytek Biosciences (CTKB) stock does not pay dividends to its shareholders.
What is the beta indicator for Cytek Biosciences?
Cytek Biosciences (CTKB) has a beta rating of 1.32. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.